Atlas Trials

Effects of Rosiglitazone on Serum Ghrelin and Peptide YY Levels

Clinical trial NCT00522470 · COMPLETED

Trial details

NCT number
NCT00522470
Sponsor
Baskent University
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Type 2 Diabetes MellitusObesity

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.